Related Experiment Video
Updated: Feb 8, 2026

Evaluation of Motor Impairment in C. elegans Models of Amyotrophic Lateral Sclerosis
Published on: September 2, 2021
Riluzole-Triazole Hybrids as Novel Chemical Probes for Neuroprotection in Amyotrophic Lateral Sclerosis
Joseph B Sweeney1, Marcus Rattray2, Victoria Pugh2,3
1Department of Chemistry, Lancaster University, Lancaster LA1 4YB, U.K.
Abstract:
Despite intense attention from biomedical and chemical researchers, there are few approved treatments for amyotrophic lateral sclerosis (ALS), with only riluzole (Rilutek) and edaravone (Radicava) currently available to patients. Moreover, the mechanistic basis of the activity of these drugs is currently not well-defined, limiting the ability to design new medicines for ALS. This Letter describes the synthesis of triazole-containing riluzole analogues, and their testing in a novel neuroprotective assay. Seven compounds were identified as having neuroprotective activity, with two compounds having similar activity to riluzole.
Related Concept Videos
Hybrid Zones
Hybridization of Atomic Orbitals I
Lateralization
Hybridization of Atomic Orbitals II
Chemical Formulas
Chemical Equations

